Emergence of Fosfomycin Resistance Among ESBL‐Producing Escherichia coli in Abadan, Southwestern Iran
Nabi Jomehzadeh, Ali Fakari · 2026
Read Emergence of Fosfomycin Resistance Among ESBL‐Producing Escherichia coli in Abadan, Southwestern Iran by Nabi Jomehzadeh, Ali Fakari (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13247132.txt.
Description
Jomehzadeh and Fakari checked whether a reserve antibiotic is losing ground in Abadan, southwestern Iran, in this 2026 Health Science Reports study. Fosfomycin is an older drug increasingly used against E. coli strains producing extended-spectrum beta-lactamases, enzymes that defeat many standard antibiotics. The team collected ninety clinical isolates in 2020 and 2021, testing drug susceptibility and screening for resistance genes.
About a third of isolates produced the resistance enzymes, and over half of those carried the main CTX-M gene. Outright fosfomycin resistance was still uncommon, in roughly one isolate in eighteen, but warning genes circulated: half of the enzyme producers carried a glpT change and a minority carried fosA3. The authors urge continued local surveillance to protect a valuable fallback drug.
Catalog record
| CREATOR | Nabi Jomehzadeh, Ali Fakari |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |